ABSTRACT
BACKGROUND AND AIMS: Haemodialysis (HD) patients tend to be old, have weakened immune systems and suffer from multiple comorbidities, making them particularly prone to infections and death by the Coronavirus disease 2019 (COVID-19). Global vaccination against SARS-CoV2 has been underway, but long-term data in dialysis patients are still scant. We aimed to study the seroconversion with the Pfizer BNT162b2 vaccine in HD patients of 5 Dialysis Centres after the first 2 doses and monitor the immune responses and clinical data during the following 7 months. We also investigated the security of the vaccine. METHOD: We included 404 patients on chronic HD. All patients received 2 shots of the Pfizer BNT162b2 vaccine, separated by 21 days. Serologic tests were run using Quant II IgG anti-Spike SARS-CoV-2 assay by Abbott. Blood was drawn 21 days after the first dose (D22), 21 days after the second dose (D43), 3 and 6 months after the first dose (M3 and M6, respectively). We asked the patients to answer written questionaries about the symptoms reported during the 7 days after each vaccination. RESULTS: 60.6% of our patients were male and the median age was 70 years (min 19, max 97). 26 patients (6.4%) had previously been infected with COVID-19. 6 of them (23.1%) needed hospitalization. At 7 months follow-up, there were 3 new cases and 1 death (the one who died had negative antibody counts at M3). Maximum response to the vaccine was seen at D43, with 97.3% of the patients showing positive antibody titers. At 6 months, 91.5% still had positive antibodies. As is reported in Table 1, the following patients had higher antibody titers at D43 and M6: patients with COVID-19 before the first vaccine, younger patients, patients with higher albumin levels, patients on HDF versus HD. Patients on HDF had higher titers at all moments during the 6 months (Figure 1). Patients with cancer without antineoplasic treatment in the last 6 months showed lower rates of seroconversion at D43: OR: 0.117 [95% confidence interval (95% CI) 0.016-0.863]} and M6 (OR: 0.203, 95% CI 0.049-0.842]. Patients whose levels of C-reactive protein was ≤ 2.8 mg/dL had more probability of seroconversion at D43 (OR: 7.840, 95% CI 1.839-33.419;P < 0.005) as well as those with a higher (better) Karnofsky scale (OR 1.062, 95% CI 1.016-1.110). 43.4% of the patients reported at least one side effect after the first shot and 64.6% after the second shot. A total of 69.1% had at least one-side effect on the first or second shot. All the reported reactions were mild and transitory. CONCLUSION: Patients on HD respond surprisingly well to anti-COVID-19 vaccination and present only mild side effects. Further studies should analyze the impact of HDF on immune responses, since our work suggests that this type of dialysis may have a positive and protective long-term role on this population.
ABSTRACT
Objectives: to analyze the frequency of anxiety, stress and depression in Brazilians during the COVID-19 pandemic period.
ABSTRACT
Introduction: Since the new coronavirus (SARS-CoV-2) was declared a pandemic, health care was one of the fields that underwent significant changes. Telemedicine, that uses technological and communication resources to provide health care, was deemed a safe alternative to continue patient care while quarantine and social isolation measures were in place. Objective: To analyze the perception of women treated at an outpatient clinic in relation to remote health care implemented during the COVID-19 pandemic. Methods: Descriptive research conducted at the Women’s Physiotherapy Outpatient Clinic of the Prof. Fernando Figueira Comprehensive Medicine Institute (IMIP) in Recife, Pernambuco state, Brazil. The study included women above the age of 18 years who were being remotely treated and excluded those who discontinued treatment. Data were collected from November 2020 to July 2021, using a questionnaire which was sent to the participants via WhatsApp. Results: Twenty-six women with an average age of 52 ± 10.1 years were interviewed. Most (61.54%) were being treated for urinary incontinence at the outpatient clinic and 38.5% had been undergoing physiotherapy for at least six months. A total of 92.3% of the participants reported feeling safe with remote health care and 70.4% noticed an improvement in their symptoms. Conclusion: Most patients noticed an improvement in their symptoms, felt comfortable and safe with teleservices and would agree to continue even after returning to in-person care. However, to ensure more effective results, patients need to be well informed and have some prior knowledge about the proposed treatment. © 2022,Fisioterapia em Movimento. All Rights Reserved.
ABSTRACT
Objectives: to analyze the frequency of anxiety, stress and depression in Brazilians during the COVID-19 pandemic period. Methods: cross-sectional study conducted with Brazilians during the COVID-19 pandemic. Data collection was performed via an online electronic form containing self-reported sociodemographic and mental health variables using the Depression, Anxiety and Stress Scale (DASS-21) using the snow-ball sampling technique. For the whole study, a significance level of 0.05 was considered, except for the application of the stepwise method, which considered a level of 0.2. Results: 1,775 people responded the survey, mostly women (78.07%), white (58.13%), single (45.78%), currently working (63.74%). 32.03% received psychotherapy or some type of emotional support before the pandemic, 19.03% had some psychiatric diagnosis and 8.49% started some support after the beginning of the pandemic. The mean scores investigated by the DASS-21 scale were 5.53869 for depression, 4.467334 for anxiety and 8.221202 for stress. Conclusions: during the COVID-19 pandemic, sociodemographic and mental health characteristics were mapped and in Brazilians and the symptoms of anxiety, depression and stress were identified mainly in women, single people, who did not currently work and already had some previous mental health symptom.